EI
GBT

Ellevest Inc’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Ellevest Inc’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19
Closed -$1K – 2013
2022
Q3 		$1K Buy
19
+16
+533% +$882 ﹤0.01% 1564
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1812
2022
Q1 		$0 Buy
+3
New +$90 ﹤0.01% 1716
2021
Q4 		– Sell
-146
Closed -$4K – 1748
2021
Q3 		$4K Buy
146
+18
+14% +$529 ﹤0.01% 1041
2021
Q2 		$4K Buy
128
+24
+23% +$937 ﹤0.01% 954
2021
Q1 		$4K Buy
104
+3
+3% +$138 ﹤0.01% 976
2020
Q4 		$4K Buy
101
+92
+1,022% +$4.54K ﹤0.01% 888
2020
Q3 		$0 Hold
9
– – ﹤0.01% 1372
2020
Q2 		$1K Sell
9
-5
-36% -$343 ﹤0.01% 1086
2020
Q1 		$1K Buy
14
+1
+8% +$67 ﹤0.01% 1030
2019
Q4 		$1K Buy
+13
New +$770 ﹤0.01% 921

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ellevest Inc's GBT Position: Q4 2022 in Review

Ellevest Inc sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 19 shares — an estimated $1K sold.

Ellevest Inc first reported a position in GBT in Q4 2019 and held it in 11 quarters. The position peaked at $4K in Q3 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Ellevest Inc reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Ellevest Inc sold 19 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1K.
  • Ellevest Inc first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 11 quarters.
  • Ellevest Inc's Global Blood Therapeutics, Inc. position peaked at $4K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.